Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention
Fabio Angeli(University of Insubria), Claudio Cavallini, Stefano De Servi(University of Pavia), Gustavo Arraiz, Stefano Savonitto, Chiara Cosma(University of Padua), Carlo Briguori, Paolo Verdecchia(Azienda Ospedaliera di Perugia), Andrea Broccatelli, Giuseppe Ambrosio(University of Perugia), Martina Zaninotto(University of Padua), Federico Sabino(Bracco (Italy))
Cited by 25
Related Papers
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
European Society of Hypertension Position Paper on Ambulatory Blood Pressure Monitoring
|Journal of Hypertension|2013|1.4k
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
|European Journal of Internal Medicine|2020|1.3k
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring
|Journal of Hypertension|2014|1k